The Kaplan-Meyer survival analysis results demonstrated that GC patients with high NF1 protein expression had a longer five-year overall survival than GC patients with low or negative NF1 protein expression (χ2=20.732, P<0.001; Figure 2A). Here, NF1 is linked to gastric cancer.